Description: Update of the 2004 U.S. Preventive Services Task

Force (USPSTF) recommendation statement on screening for blad-der cancer. Methods: The USPSTF performed a targeted literature search for new evidence on the benefits and harms of screening, the accuracy of primary care–feasible screening tests, and the benefits and harms of treatment. Recommendation: The USPSTF concludes that the current evi-dence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults (I statement). Ann Intern Med. 2011;155:246-251. www.annals.org For author affiliation, see end of text. * For a list of the members of the USPSTF, see the Appendix (avaible at www.annals.org). The U.S. Preventive Services Task Force (USPSTF) makesrecommendations about preventive care services for pa-tients without recognized signs or symptoms of the target condition. It bases its recommendations on a systematic review of the evidence of the benefits and harms and an assessment of the net benefit of the service. The USPSTF recognizes that clinical or policy decisions involve more considerations than this body of evidence alone. Clinicians and policymakers should understand the evidence but individualize decision making to the specific patient or situation. SUMMARY OF RECOMMENDATION AND EVIDENCE The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults (I statement). See the Clinical Considerations section for additional information and suggestions for practice regarding the I statement for screening. See the Figure for a summary of the recommendation and suggestions for clinical practice